doi: 10.18632/oncotarget.19695 133 PengYLinHTianSLiuSLiJLvXet al
For MOTS-c, research protocols discussed in investigational contexts vary widely, but often involve subcutaneous administration of 5-15 mg, 2-3 times weekly
BPC-157 + GHK-Cu For regeneration and anti-aging: BPC-157: 250-500mcg twice daily GHK-Cu: 1-2mg, 3-5x weekly Tissue regeneration focus Benefits: BPC-157: Healing and repair GHK-Cu: Collagen synthesis, copper delivery Great for skin, connective tissue See our copper peptides GHK-Cu guide
Anti-PCSK9 antibodies, such as evolocumab and alirocumab, block the PCSK9 interaction with LDL receptor and have demonstrated robust LDL-C reductions in hypercholesterolemic patients 8
Obesity: Assessment and treatment across the care continuum, Annals of Medicine
Absorption enhancement effect of acylcarnitines through changes in tight junction protein in Caco-2 cell monolayers